Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07091058 · ClinicalTrials.gov registry record
Harmful Algal Blooms
A clinical trial of Red Tide, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT07091058: Recruiting study of Red Tide, sponsored by University of Central Florida.
NCT07091058 is a study of Red Tide that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07091058, a study of Red Tide, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the frequency of symptoms, exposure and health impacts in persons living in areas where they are exposed to bloom and non-bloom periods of cyanobacteria and red tide in Florida.
Primary Outcome
These data will be linked to determine if and how much contact the participant may have had with Florida waters, presence of cyanotoxin in the bio samples (blood, nasal swabs, and urine) and self-reported health issues to determine the impact of harmful algal blooms (HABs) on human health. In addition, this study will explore a potential link between self-reported COVID-19 exposure/infection and susceptibility to cyanotoxins and establish a HAB biorepository.
Conditions Studied
Study Locations (1)
Florida
- University of Central Florida - Multiple Locations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-11-13 |
| Est. Completion | 2026-06-30 |
What NCT07091058 shows while recruiting
NCT07091058 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Red Tide appearing as the primary indexed condition, and to 0 interventions.
NCT07091058 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07091058 about?
NCT07091058 is a clinical study titled "Harmful Algal Blooms". The purpose of this study is to compare the frequency of symptoms, exposure and health impacts in persons living in areas where they are exposed to bloom and non-bloom periods of cyanobacteria and red tide in Florida.
What is the current status of trial NCT07091058?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2024-11-13. Estimated completion is 2026-06-30.
What conditions does trial NCT07091058 study?
This clinical trial studies the following conditions: Red Tide.
Who is sponsoring clinical trial NCT07091058?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07091058 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Red Tide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI